17

Osimertinib as adjuvant therapy in patients with stage IB ......Herbst 1.0 0.8 0.2 0.0 115 stage IllA Time from randomization (months) #ASC020 PRESENTED Roy S. Early snapshot: overall

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Osimertinib as adjuvant therapy in patients with stage IB–IIIA EGFR mutation positive NSCLC after complete tumor resection: ADAURA